clinical trial · NCT07273656
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
University Hospital, Lille·phase3·not yet recruiting·n = 59
KeratosisActinic KeratosesCryotherapy + Tirbanibulin
brief summary
The aim of the study is to evaluate the efficacy and safety of a combined approach of cryotherapy and tirbanibulin for the treatment of actinic keratosis of the scalp and forehead, repeated every 4 months. A higher rate of complete response is expected with this combination compared to cryotherapy alone, as well as a better response with repeated treatment cycles.
started
Nov 30, 2025
primary completion
Nov 30, 2027
completion
Nov 30, 2027
last updated
Dec 9, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol